Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

COLL

Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:COLL
일자시간출처헤드라인심볼기업
2025/01/1106:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2025/01/0822:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
2025/01/0822:00GlobeNewswire Inc.Collegium Provides 2025 Financial Guidance and Business UpdateNASDAQ:COLLCollegium Pharmaceutical Inc
2024/11/1506:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/11/1506:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/11/1222:00GlobeNewswire Inc.Collegium to Participate in Upcoming Investor ConferencesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/11/0806:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COLLCollegium Pharmaceutical Inc
2024/11/0806:02GlobeNewswire Inc.Collegium Reports Record Third Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
2024/11/0806:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
2024/11/0806:01GlobeNewswire Inc.Collegium Appoints Vikram Karnani as Chief Executive OfficerNASDAQ:COLLCollegium Pharmaceutical Inc
2024/10/2421:00GlobeNewswire Inc.Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
2024/09/1805:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/09/1323:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/09/1323:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/09/0706:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/09/0700:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/09/0605:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/09/0421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
2024/08/3021:00GlobeNewswire Inc.Collegium to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:COLLCollegium Pharmaceutical Inc
2024/08/2821:00GlobeNewswire Inc.Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024NASDAQ:COLLCollegium Pharmaceutical Inc
2024/08/1605:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:COLLCollegium Pharmaceutical Inc
2024/08/1303:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/08/1005:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
2024/08/0905:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COLLCollegium Pharmaceutical Inc
2024/08/0905:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
2024/08/0905:01GlobeNewswire Inc.Collegium Reports Second Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
2024/07/2919:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
2024/07/2919:00GlobeNewswire Inc.Collegium to Acquire Ironshore Therapeutics, Expanding into NeurologyNASDAQ:COLLCollegium Pharmaceutical Inc
2024/07/2521:00GlobeNewswire Inc.Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
2024/06/1321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
 검색 관련기사 보기:NASDAQ:COLL